Related references
Note: Only part of the references are listed.Chemotherapy-Induced Hepatitis B Reactivation in Lymphoma Patients With Resolved HBV Infection: A Prospective Study
Chiun Hsu et al.
HEPATOLOGY (2014)
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group
Seok Jin Kim et al.
EUROPEAN JOURNAL OF CANCER (2013)
Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B
Yi-Hsiang Huang et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Management of B-cell non-Hodgkin lymphoma in Asia: resource-stratified guidelines
Daryl Tan et al.
LANCET ONCOLOGY (2013)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports
A. M. Evens et al.
ANNALS OF ONCOLOGY (2011)
Racial Differences in the Presentation and Outcomes of Diffuse Large B-Cell Lymphoma in the United States
Pareen J. Shenoy et al.
CANCER (2011)
Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size
Zhuanbo Luo et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Seroprevalence and Risk Factors for Hepatitis B Infection in an Adult Population in Northeast China
Hong Zhang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2011)
Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy
Shigeru Kusumoto et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Association of Hepatitis B Virus Pre-S Deletions with the Development of Hepatocellular Carcinoma in Chronic Hepatitis B
Pok Yeung et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors
Dong Hee Seo et al.
TRANSFUSION (2011)
Relative Roles of HBsAg Seroclearance and Mortality in the Decline of HBsAg Prevalence With Increasing Age
Dar-In Tai et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Humoral Responses After Influenza Vaccination Are Severely Reduced in Patients With Rheumatoid Arthritis Treated With Rituximab
Sander van Assen et al.
ARTHRITIS AND RHEUMATISM (2010)
Clearance of Hepatitis B Surface Antigen and Risk of Hepatocellular Carcinoma in a Cohort Chronically Infected with Hepatitis B Virus
Josephine Simonetti et al.
HEPATOLOGY (2010)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab
Winnie Yeo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
HBsAg seroclearance in chronic hepatitis B in Asian patients: Replicative level and risk of hepatocellular carcinoma
Man-Fung Yuen et al.
GASTROENTEROLOGY (2008)
Predicting response to HBV vaccination in people with positive anti-HBc but negative HBsAg and anti-HBs
Ali Kabir et al.
HUMAN VACCINES (2008)
Evaluation of the Abbott RealTime HBV DNA assay and comparison to the cobas AmpliPrep/Cobas TaqMan 48 assay in monitoring patients with chronic cases of hepatitis B
Marco Ciotti et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Drug Insight: the mechanism of action of rituximab in autoimmune disease - the immune complex decoy hypothesis
Ronald P. Taylor et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
Occult hepatitis B virus infection
Giovanni Raimondo et al.
JOURNAL OF HEPATOLOGY (2007)
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone:: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group
W Hiddemann et al.
BLOOD (2005)
Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia
LH Sehn et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology
AMS Muller et al.
ANNALS OF HEMATOLOGY (2005)
Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy
W Yeo et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
JCW Edwards et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab.
I Dervite et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
